YW-1128

N/A

Report date: 2025/01/26 16:21:48
NME

Base Information

Drug NameYW-1128
Drug Alias NameWNT/beta-catenin inhibitor (University of Maryland)YW-1128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWingless type MMTV integration site family protein modulatorsCatenin beta 1 degraders
TargetsCatenin beta 1Wingless type MMTV integration site family protein
Therapy Area/IndicationsLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Medical UniversityUniversity Of Maryland
Inactive CompaniesN/A
Active IndicationsLipid Metabolism DisordersMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsNutritional and Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A